Fulminant hepatitis type B after chemotherapy in a serologically negative hepatitis B virus carrier with acute myelogenous leukemia

International Journal of Hematology

Volumn 73, Issue 1, 2001, Pages 115-118

  Ishiga, Kiyomi ^a   Kawatani, Toshio ^a   Suou, Takeaki ^a   Tajima, Fumihito ^a   Omura, Hiromi ^a   Idobe, Youko ^a   Kawasaki, Hironaka ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Acute myelogenous leukemia; Fulminant hepatitis; Hepatitis B virus

Indexed keywords

ANTINEOPLASTIC AGENT; VIRUS DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BLOOD; CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER FAILURE; MALE; POLYMERASE CHAIN REACTION; VIROLOGY; VIRUS ACTIVATION;

ADULT; ANTINEOPLASTIC AGENTS; DNA, VIRAL; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IMMUNOSUPPRESSION; LEUKEMIA, MYELOCYTIC, ACUTE; LIVER FAILURE; MALE; POLYMERASE CHAIN REACTION; VIRUS ACTIVATION;

EID: 0035222806     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02981912     Document Type: Article

References (2)

1. Lok ASF, Liang RHS, Chiu EKW, Wong K-L, Chan T-K, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Gastroenterology. 1991;100:182-188.
2. Lau GKK, Liang R, Chiu EKW, Lee CK, Lam SK. Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study. Bone Marrow Transplant. 1997; 19:795-799.